Experimental and Molecular Pathology
Impact Factor Trend (2018–2026)
Clarivate IF trend for Experimental and Molecular Pathology
SCImago Journal Rank citation prestige weighting
84 papers with at least that number of citations each
Aims & Scope
Under new editorial leadership, Experimental and Molecular Pathology presents original articles on disease processes in relation to structural and biochemical alterations in mammalian tissues and fluids and on the application of newer techniques of molecular biology to problems of pathology in humans and other animals. The journal also publishes selected interpretive synthesis reviews by bench level investigators working at the "cutting edge" of contemporary research in pathology. In addition, special thematic issues present original research reports that unravel some of Nature's most jealously guarded secrets on the pathologic basis of disease. Research Areas include: Stem cells; Neoangiogenesis; Molecular diagnostics; Polymerase chain reaction; In situ hybridization; DNA sequencing; Cell receptors; Carcinogenesis; Pathobiology of neoplasia; Complex infectious diseases; Transplantation; Cytokines; Flow cytomeric analysis; Inflammation; Cellular injury; Immunology and hypersensitivity; Athersclerosis.
Special Issues
Calls for Papers3 Calls for Papers · Automatically synced from ScienceDirect & publishers
WoS Categories & Quartiles
Detailed JCR / JCI category rankings and quartile breakdown from Clarivate
PATHOLOGY
PATHOLOGY
Annual Historical Statistics & Publications
Track annual publication volume, total citations, and Impact Factor evolution
SCImago & Scopus Journal Intelligence
Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact
Weighted prestige citation metric per document indexed in the Scopus database.
Average citations received per document published in the 2-year window.
Estimated Article Processing Charge for Open Access publication.
Scopus 3-Year Publication & Citation Window
Aggregated from Scopus database across the 3-year SJR evaluation window.
Societal Impact & Inclusivity (SCImago)
Citations in government and international policy documents
Percentage of female authors published in the journal
Real-world societal policy reach and author gender diversity tracked by SCImago.
Scopus Subject Categories
Journal Metrics & Citation Visualizations
Total Cites vs Self-Cites
Evaluation of scholarly independence and citation reach
Citations per Document
Citation metric windows across 2, 3, and 4 years
Chinese Academy of Sciences (CAS) Classification
Major / minor zone classification and CAS Early Warning List history
Academic Intelligence Overview & Context
ImpaQ AnalysisExperimental and Molecular Pathology (acronym: emp, abbr: EXP. MOL. PATHOL, ISSN: 0014-4800) is a peer-reviewed international scholarly journal in the field of Medicine, published by Academic Press Inc. in United States since 1962. The periodical holds a Journal Impact Factor (JIF) of 4.10, ranking in quartile Q1 of Web of Science (SCIE), a Scopus SJR indicator of 1.109 (Q1), an H-index of 84.
The journal enforces rigorous peer evaluation with an average review speed of 11.5周, a publication frequency of Bimonthly, an annual output of approximately 106 scientific articles. In terms of accessibility and author fees, it operates under the Gold OA model with an estimated APC of $3,218 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.
Publishing & Editorial Information
Detailed publisher, peer-review turnaround, and publication cycle specifications
Similar Journals in Discipline
Journals in the same research field with comparable impact metrics